Pharmaceutical company
NAVEGAL LABORATORIES
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
110products
52generics
3therapeutic areas
110current prices
Portfolio intelligence
Therapeutic mix
Unclassified 98Proton pump inhibitors 6Third-generation cephalosporins 3Fluoroquinolone antibacterials 3
Company portfolio
110 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| Navexim Dry syp | Cefixime | 100 mg/5 mL | Suspension | 60ml | 043931 | PKR 424.71 |
| Navexim Dry syp | Cefixime | 200 mg/5 mL | Suspension | 30ml | 043932 | PKR 384.56 |
| Ofira | Tenofovir disoproxil | 300 mg | Tablet | 1 | 068236 | PKR 212.36 |
| Ofira | Tenofovir disoproxil | 300 mg | Tablet | 30 | 068236 | PKR 6,370.72 |
| Pipin | Omeprazole | 40 mg | Powder for injection | 1 | 105314 | PKR 553.98 |
| Pipin | Omeprazole | 40 mg | Capsule | 14 | 043980 | PKR 461.65 |
| Pipin | Omeprazole | 40 mg | Capsule | 3x7's | 043980 | PKR 664.77 |
| Pipin | Omeprazole | 20 mg | Capsule | 14 | 043978 | PKR 265.91 |
| Previr | Entecavir | 1 mg | Tablet | 30 | 056602 | PKR 31,391.95 |
| Previr | Entecavir | 0.5 mg | Tablet | 30 | 056601 | PKR 18,835.17 |
| Pudex | Ciprofloxacin | 500 mg | Tablet | 10 | 043964 | PKR 332.39 |
| Pudex | Ciprofloxacin | 250 mg | Tablet | 10 | 043963 | PKR 240.06 |
| Pudex | Ciprofloxacin | 750 mg | Tablet | 10 | 043962 | PKR 424.71 |
| Quit | Quetiapine | 200 mg | Tablet | 30 | 068241 | PKR 1,846.59 |
| Quit | Quetiapine | 25 mg | Tablet | 30 | 068244 | PKR 553.98 |
| Quit | Quetiapine | 200 mg | Tablet | 10 | 068241 | PKR 830.96 |
| Quit | Quetiapine | 25 mg | Tablet | 10 | 068244 | PKR 184.66 |
| Quit | Quetiapine | 25 mg | Tablet | 20 | 068244 | PKR 369.32 |
| Quit XR | Quetiapine | 300 mg | Extended-release tablet | 10 | 078467 | PKR 1,196.59 |
| Sinex | Levofloxacin | 500 mg | Tablet | 10 | 045562 | PKR 768.18 |